Cardio Diagnostics Cash And Short Term Investments Over Time
| CDIO Stock | USD 0.30 0.01 3.23% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cardio Diagnostics Performance and Cardio Diagnostics Correlation. Cardio |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share 0.002 | Quarterly Revenue Growth 3.562 | Return On Assets (0.98) | Return On Equity (2.93) |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash And Short Term Investments Analysis
Compare Cardio Diagnostics and related stocks such as Immix Biopharma, Cns Pharmaceuticals, and Effector Therapeutics Cash And Short Term Investments Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMX | 734 K | 734 K | 734 K | 734 K | 734 K | 734 K | 734 K | 734 K | 734 K | 734 K | 391.1 K | 17.6 M | 13.4 M | 17.5 M | 10.9 M |
| CNSP | 110.5 K | 110.5 K | 110.5 K | 110.5 K | 110.5 K | 110.5 K | 110.5 K | 110.5 K | 282.7 K | 7.2 M | 14 M | 5 M | 10.1 M | 548.7 K | 521.3 K |
| SONN | 14.2 K | 151.9 K | 1.2 M | 442.7 K | 245.8 K | 1.5 M | 438.5 K | 35.7 K | 524.1 K | 7.3 M | 27.6 M | 3.1 M | 2.3 M | 524.1 K | 497.9 K |
| ZURA | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 13.8 K | 99.8 M | 104.8 M |
| PHIO | 503 K | 503 K | 5.1 M | 14.4 M | 8.5 M | 10.6 M | 12.9 M | 3.6 M | 14.9 M | 6.9 M | 14.2 M | 24.1 M | 11.8 M | 8.5 M | 11.5 M |
| ATNF | 67.2 K | 67.2 K | 67.2 K | 67.2 K | 67.2 K | 67.2 K | 67.2 K | 117 M | 118.4 M | 83.4 K | 8.2 M | 8.2 M | 7 M | 2 M | 1.9 M |
| PYXS | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 8.1 M | 274.7 M | 179.3 M | 119.3 M | 132.2 M |
| CYTO | 825.7 K | 825.7 K | 64 K | 23.9 M | 56.9 M | 50.2 M | 32.4 M | 15 M | 5.4 M | 1.4 M | 11.3 M | 984.2 K | 15.4 K | 617.4 K | 586.5 K |
| ELEV | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 79.4 M | 146.3 M | 90.3 M | 83.1 M | 88.2 M |
| ZVSA | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 174.7 K | 328.6 K | 5.9 M | 3.1 M | 2.6 M |
Cardio Diagnostics and related stocks such as Immix Biopharma, Cns Pharmaceuticals, and Effector Therapeutics Cash And Short Term Investments description
Short Term Investments is an account in the current assets section of Cardio Diagnostics balance sheet. This account contains Cardio Diagnostics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Cardio Diagnostics Holdings fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.My Equities
My Current Equities and Potential Positions
| Cardio Diagnostics Holdings | CDIO |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Illinois; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.3
Check out Cardio Diagnostics Performance and Cardio Diagnostics Correlation. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Cardio Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.